(lp0
S"Genomic Health Inc.  Moves Higher on Volume Spike for March 17 Equities.com - 17 hours ago Genomic Health Inc.  traded on unusually high volume on Mar. 17, as the stock gained 0.09% to close at $31.85. On the day, Genomic Health Inc. saw 402,766 shares trade hands on 1,448 trades. Considering that the stock averages only a daily&nbsp;...Genomic Health, Inc.'s  stock price is Worth at $31.85 while finishes ... - Hot Stocks Point"
p1
aS"Genomic Health, Inc. Earnings: Waiting for  Reimbursement Motley Fool - May 11, 2016 Kim Popovits, Genomic Health's chairman, CEO, and president, hinted that there might be a backlog of prostate cancer tests that the company hasn't reported yet: &quot;We are only reporting tests delivered, so we're not reporting tests ordered but tests ..."
p2
aS"Genomic Health, Inc.: Almost at Breakeven Motley Fool - Nov 3, 2016 2015, that validated the company's invasive breast cancer test and reaccelerated growth of the test. The number of prostate cancer tests delivered increased 6% year over year, which isn't that great for an up-and-coming test, but Genomic Health has a ..."
p3
aS"3 Things to Watch as Genomic Health, Inc. Releases Earnings Motley Fool - May 3, 2016 Revenue is important, but with not all of its tests being reimbursed, the number of tests performed is a better indicator of the company's long-term trajectory . Management guided for Genomic Health to ..."
p4
aS'Genomic Health, Inc. Pushes Toward Profitability Motley Fool - Aug 4, 2016 Genomic Health launched its first liquid-biopsy test, Oncotype SEQ, and licensed a second one from Epic Sciences, pushing into sequencing-based blood tests.'
p5
aS'Why Genomic Health, Inc. Earned a Higher Share Price Motley Fool - May 5, 2016 What: Genomic Health  is up 11% at 12 p.m. ET after reporting solid earnings following the bell yesterday. So what: Revenue increased 19% year over year while tests delivered increased 16%.'
p6
aS"Option Market: Genomic Health Inc Risk Hits A Lowered Level CML News - Mar 13, 2017 We're going to look at a proprietary risk rating for the next 30-days built by Capital Market Laboratories  based on a large number of interactions of data points, many of which come directly from the option market for Genomic Health Inc&nbsp;..."
p7
aS"Genomic Health and Epic Sciences Announce Strategic Collaboration to Deliver ... PR Newswire  - Jul 7, 2016 REDWOOD CITY, Calif. and SAN DIEGO, July 7, 2016 /PRNewswire/ -- Genomic Health, Inc.  and Epic Sciences, Inc. today announced an exclusive agreement to commercialize Epic Sciences' novel AR-V7 liquid biopsy test in the United&nbsp;...Genomic Health to Market Epic Sciences' AR-V7 Liquid Biopsy Test - GenomeWeb"
p8
aS'Genomic Health to Present at the 35th Annual JP Morgan Healthcare Conference PR Newswire  - Sep 28, 2016 3, 2017 /PRNewswire/ -- Genomic Health, Inc.  today announced that Kim Popovits, chairman of the board, chief executive officer and president, will present at the 35th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis&nbsp;...'
p9
aS'Genomic Health to Present at the Cowen and Company 37th Annual Health Care ... PR Newswire  - Feb 16, 2017 REDWOOD CITY, Calif., Feb. 28, 2017 /PRNewswire/ -- Genomic Health, Inc.  today announced that Kim Popovits, chairman of the board, chief executive officer and president, will present at the Cowen and Company 37th Annual Health&nbsp;...'
p10
a.